Complex antioxidant blend improves memory in community-dwelling seniors
- PMID: 20110592
- DOI: 10.3233/JAD-2010-1229
Complex antioxidant blend improves memory in community-dwelling seniors
Abstract
One hundred thirteen community dwelling subjects between the ages of 50 and 75 without dementia were recruited. A blind administrator randomly assigned 54 subjects to placebo and 59 to active treatment groups. The active treatment consisted of four months treatment with a complex antioxidant blend. Placebo treatment was an identical gel and bottle administered for four months. Forty-eight active subjects and 38 placebo subjects completed the study. Memory testing with a 50 part paired association test and a 20-word immediate recall test were significantly improved, p=0.015 and p=0.005 respectively. A secondary study of serum homocysteine was completed in 25 active treatment subjects and 17 placebo subjects. Significant reduction in serum homocysteine levels was seen in the active treatment subjects (p=0.005). A complex antioxidant blend taken over four months improves performance on two difficult memory tests in community dwelling elderly subjects. Furthermore, the antioxidant significantly reduced the serum homocysteine level in treatment group.
Similar articles
-
Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation.Prev Med. 2005 Jul;41(1):253-9. doi: 10.1016/j.ypmed.2004.11.007. Epub 2005 Jan 6. Prev Med. 2005. PMID: 15917019 Clinical Trial.
-
[A follow-up study on a randomized, single-blind control of King's Brain pills in treatment of memory disorder in elderly people with MCI in a Beijing community].Zhongguo Zhong Yao Za Zhi. 2003 Oct;28(10):987-91. Zhongguo Zhong Yao Za Zhi. 2003. PMID: 15620194 Clinical Trial. Chinese.
-
Performance of illiterate and literate nondemented elderly subjects in two tests of long-term memory.J Int Neuropsychol Soc. 2004 Jul;10(4):634-8. doi: 10.1017/S1355617704104062. J Int Neuropsychol Soc. 2004. PMID: 15327741
-
The salutary effects of antioxidant vitamins on the plasma lipids of healthy middle aged-to-elderly individuals: a randomized, double-blind, placebo-controlled study.J Med Liban. 2002 Jan-Apr;50(1-2):10-3. J Med Liban. 2002. PMID: 12841306 Clinical Trial.
-
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.Int J Geriatr Psychiatry. 2006 Jun;21(6):550-5. doi: 10.1002/gps.1523. Int J Geriatr Psychiatry. 2006. PMID: 16642542
Cited by 12 articles
-
The Presence of Caffeic Acid in Cerebrospinal Fluid: Evidence That Dietary Polyphenols Can Cross the Blood-Brain Barrier in Humans.Nutrients. 2020 May 25;12(5):1531. doi: 10.3390/nu12051531. Nutrients. 2020. PMID: 32466115 Free PMC article.
-
Lawsonia Inermis Markedly Improves Cognitive Functions in Animal Models and Modulate Oxidative Stress Markers in the Brain.Medicina (Kaunas). 2019 May 22;55(5):192. doi: 10.3390/medicina55050192. Medicina (Kaunas). 2019. PMID: 31121979 Free PMC article.
-
The Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910) addendum: neuroimaging and gut microbiota protocol.Nutr J. 2019 Jan 5;18(1):1. doi: 10.1186/s12937-018-0428-9. Nutr J. 2019. PMID: 30611275 Free PMC article. Clinical Trial.
-
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD011906. doi: 10.1002/14651858.CD011906.pub2. Cochrane Database Syst Rev. 2018. PMID: 30556597 Free PMC article.
-
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.Cochrane Database Syst Rev. 2018 Nov 1;11(11):CD011905. doi: 10.1002/14651858.CD011905.pub2. Cochrane Database Syst Rev. 2018. PMID: 30383288 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
